CA2763730A1 - Heterocyclylaminopyrimidines servant d'inhibiteurs de kinases - Google Patents

Heterocyclylaminopyrimidines servant d'inhibiteurs de kinases Download PDF

Info

Publication number
CA2763730A1
CA2763730A1 CA2763730A CA2763730A CA2763730A1 CA 2763730 A1 CA2763730 A1 CA 2763730A1 CA 2763730 A CA2763730 A CA 2763730A CA 2763730 A CA2763730 A CA 2763730A CA 2763730 A1 CA2763730 A1 CA 2763730A1
Authority
CA
Canada
Prior art keywords
amino
pyrazol
methanesulfonamide
pyrimidin
ylamino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA2763730A
Other languages
English (en)
Inventor
Mihiro Sunose
Jeremy Major
Richard John Harrison
Jay Freeman
Adeline Morel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cellzome Ltd
Original Assignee
Cellzome Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cellzome Ltd filed Critical Cellzome Ltd
Publication of CA2763730A1 publication Critical patent/CA2763730A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
CA2763730A 2009-06-18 2010-06-17 Heterocyclylaminopyrimidines servant d'inhibiteurs de kinases Abandoned CA2763730A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP09163098 2009-06-18
EP09163098.8 2009-06-18
PCT/EP2010/058574 WO2010146133A1 (fr) 2009-06-18 2010-06-17 Hétérocyclylaminopyrimidines servant d'inhibiteurs de kinases

Publications (1)

Publication Number Publication Date
CA2763730A1 true CA2763730A1 (fr) 2010-12-23

Family

ID=40875012

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2763730A Abandoned CA2763730A1 (fr) 2009-06-18 2010-06-17 Heterocyclylaminopyrimidines servant d'inhibiteurs de kinases

Country Status (4)

Country Link
US (1) US20120172384A1 (fr)
EP (1) EP2443106A1 (fr)
CA (1) CA2763730A1 (fr)
WO (1) WO2010146133A1 (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2440534A2 (fr) * 2009-06-10 2012-04-18 Cellzome Limited Dérivés de pyrimidine en tant qu'inhibiteurs zap-70
EP2443095A1 (fr) * 2009-06-18 2012-04-25 Cellzome Limited Sulfonamides et sulfamides servant d'inhibiteurs de la zap-70
BR112012015651B1 (pt) 2009-12-23 2021-10-26 Takeda Pharmaceutical Company Limited Composto de pirrolidinana heteroaromática fundida, sua composição farmacêutica, seu uso e sua combinação
MA34299B1 (fr) 2010-06-04 2013-06-01 Hoffmann La Roche Dérivés d'aminopyrimidine au titre de modulateurs de lrrk2
LT3124483T (lt) 2010-11-10 2019-09-25 Genentech, Inc. Pirazolo aminopirimidino dariniai, kaip lrrk2 moduliatoriai
EP2489663A1 (fr) 2011-02-16 2012-08-22 Almirall, S.A. Composés en tant qu'inhibiteurs de la syk kinase
EP2723739B1 (fr) 2011-06-22 2016-08-24 Takeda Pharmaceutical Company Limited Dérivés de 6-aza-isoindolin-1-one substitués
RU2564419C1 (ru) * 2011-07-28 2015-09-27 Целльзом Лимитид Гетероциклические аналоги пиримидина в качестве ингибиторов jak
AU2012357038B2 (en) * 2011-12-23 2016-05-12 Cellzome Limited Pyrimidine-2,4-diamine derivatives as kinase inhibitors
AR090650A1 (es) 2012-04-12 2014-11-26 Alcon Res Ltd Tratamiento para respuestas inflamatorias inducidas por microbios en el ojo
US9013997B2 (en) 2012-06-01 2015-04-21 Broadcom Corporation System for performing distributed data cut-through
CN104926824B (zh) * 2014-03-17 2017-07-07 广东东阳光药业有限公司 取代的杂芳基化合物及其组合物和用途
JP2018527362A (ja) * 2015-09-11 2018-09-20 サンシャイン・レイク・ファーマ・カンパニー・リミテッドＳｕｎｓｈｉｎｅ Ｌａｋｅ Ｐｈａｒｍａ Ｃｏ．，Ｌｔｄ． 置換されたヘテロアリール化合物および使用方法
CN106349224A (zh) * 2016-08-03 2017-01-25 山东大学 一种含有4‑氨基‑(1h)‑吡唑结构的jak激酶抑制剂及其制备方法和应用
CN110835320A (zh) * 2018-08-15 2020-02-25 江苏奥赛康药业有限公司 二氨基嘧啶类化合物及其应用
CN112771032B (zh) * 2018-10-29 2023-01-03 江苏先声药业有限公司 作为第四代egfr抑制剂的嘧啶吡唑类化合物
CN113717156B (zh) * 2020-05-25 2023-05-09 南京红云生物科技有限公司 Egfr抑制剂、其制备方法及用途
AU2022250976A1 (en) * 2021-04-01 2023-08-17 Industry-Academic Cooperation Foundation, Yonsei University Pyrimidine derivative having protein kinase inhibitory activity, and therapeutic pharmaceutical composition comprising same

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL156368A0 (en) * 2000-12-21 2004-01-04 Vertex Pharma Pyrazole derivatives and pharmaceutical compositions containing the same
WO2005016894A1 (fr) * 2003-08-15 2005-02-24 Novartis Ag 2, 4-pyrimidine diamines utiles dans le cadre du traitement de maladies neoplasiques, de troubles inflammatoires et de troubles du systeme immunitaire
US7947698B2 (en) * 2007-03-23 2011-05-24 Rigel Pharmaceuticals, Inc. Compositions and methods for inhibition of the JAK pathway
WO2009080638A2 (fr) * 2007-12-20 2009-07-02 Cellzome Limited Sulfamides en tant qu'inhibiteurs de zap-70
EP2276747A1 (fr) * 2008-03-11 2011-01-26 Cellzome Limited Sulfonamides en tant qu'inhibiteurs de zap-70
WO2010118986A1 (fr) * 2009-04-14 2010-10-21 Cellzome Limited Composés de pyrimidine substitués par fluoro en tant qu'inhibiteurs de jak3
EP2440534A2 (fr) * 2009-06-10 2012-04-18 Cellzome Limited Dérivés de pyrimidine en tant qu'inhibiteurs zap-70
EP2443095A1 (fr) * 2009-06-18 2012-04-25 Cellzome Limited Sulfonamides et sulfamides servant d'inhibiteurs de la zap-70

Also Published As

Publication number Publication date
US20120172384A1 (en) 2012-07-05
WO2010146133A1 (fr) 2010-12-23
EP2443106A1 (fr) 2012-04-25

Similar Documents

Publication Publication Date Title
CA2763730A1 (fr) Heterocyclylaminopyrimidines servant d'inhibiteurs de kinases
US20120165332A1 (en) Sulfonamides and sulfamides as zap-70 inhibitors
AU2012288892B2 (en) Heterocyclyl pyrimidine analogues as JAK inhibitors
US20110028405A1 (en) Sulfamides as zap-70 inhibitors
US20120142667A1 (en) Pyrimidine derivatives as zap-70 inhibitors
US20110098288A1 (en) Sulfonamides as zap-70 inhibitors
US20120040955A1 (en) Fluoro substituted pyrimidine compounds as jak3 inhibitors
JP6197031B2 (ja) Ｔｙｋ２阻害剤としてのヘテロシクリルピリミジン類似体
CA2815330A1 (fr) Composes de pyridine et leurs analogues aza en tant qu'inhibiteurs de tyk2
AU2012357038B2 (en) Pyrimidine-2,4-diamine derivatives as kinase inhibitors
US20120172385A1 (en) Ortho substituted pyrimidine compounds as jak inhibitors
WO2012143320A1 (fr) Composés (7h-pyrrolo[2,3-d]pyrimidin-2-yl)amine comme inhibiteurs de la jak3
WO2013017479A1 (fr) Dérivés de pyrazolo[4,3-c]pyridine en tant qu'inhibiteurs de jak

Legal Events

Date Code Title Description
FZDE Discontinued

Effective date: 20140617